135 related articles for article (PubMed ID: 31383269)
1. Three decades of beta-lactamase inhibitors.
Drawz SM; Bonomo RA
Clin Microbiol Rev; 2010 Jan; 23(1):160-201. PubMed ID: 20065329
[TBL] [Abstract][Full Text] [Related]
2. Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase.
Pestana-Nobles R; Aranguren-Díaz Y; Machado-Sierra E; Yosa J; Galan-Freyle NJ; Sepulveda-Montaño LX; Kuroda DG; Pacheco-Londoño LC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163569
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactamases, beta-lactamase inhibitors, and skin and skin-structure infections.
Neu HC
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):896-904. PubMed ID: 2189913
[TBL] [Abstract][Full Text] [Related]
4. Utilizing Paper-Based Devices for Antimicrobial-Resistant Bacteria Detection.
Boehle KE; Gilliand J; Wheeldon CR; Holder A; Adkins JA; Geiss BJ; Ryan EP; Henry CS
Angew Chem Int Ed Engl; 2017 Jun; 56(24):6886-6890. PubMed ID: 28474847
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics in the clinical pipeline as of December 2022.
Butler MS; Henderson IR; Capon RJ; Blaskovich MAT
J Antibiot (Tokyo); 2023 Aug; 76(8):431-473. PubMed ID: 37291465
[TBL] [Abstract][Full Text] [Related]
6. Exploring complexity of class-A Beta-lactamase family using physiochemical-based multiplex networks.
Bhadola P; Deo N
Sci Rep; 2023 Nov; 13(1):20626. PubMed ID: 37996629
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations.
Bentley DJ
Antibiotics (Basel); 2024 Apr; 13(4):. PubMed ID: 38667012
[TBL] [Abstract][Full Text] [Related]
8. What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review.
Assefa GM; Roberts JA; Mohammed SA; Sime FB
J Antimicrob Chemother; 2024 May; 79(5):946-958. PubMed ID: 38459763
[TBL] [Abstract][Full Text] [Related]
9. Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae.
Tam VH; Merlau PR; Hudson CS; Kline EG; Eales BM; Smith J; Sofjan AK; Shields RK
J Antimicrob Chemother; 2022 Oct; 77(11):3130-3137. PubMed ID: 36031868
[TBL] [Abstract][Full Text] [Related]
10. The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations.
Aslan AT; Akova M
Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203879
[TBL] [Abstract][Full Text] [Related]
11.
Huang Y; Wu T; Perez O; Rana AP; Chen L; Kreiswirth BN; Satlin MJ; Bulman ZP
Front Microbiol; 2021; 12():618087. PubMed ID: 33763041
[TBL] [Abstract][Full Text] [Related]
12. Novel Beta-Lactam/Beta-Lactamase Plus Metronidazole vs Carbapenem for Complicated Intra-abdominal Infections: A Meta-analysis of Randomized Controlled Trials.
Che H; Wang J; Wang R; Cai Y
Open Forum Infect Dis; 2021 Jan; 8(1):ofaa591. PubMed ID: 33511229
[TBL] [Abstract][Full Text] [Related]
13. New β-Lactam-β-Lactamase Inhibitor Combinations.
Yahav D; Giske CG; Grāmatniece A; Abodakpi H; Tam VH; Leibovici L
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33177185
[TBL] [Abstract][Full Text] [Related]
14. Optimizing pharmacokinetics/pharmacodynamics of β-lactam/β-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria.
Tam VH; Abodakpi H; Wang W; Ledesma KR; Merlau PR; Chan K; Altman R; Tran TT; Nikolaou M; Sofjan AK
J Antimicrob Chemother; 2021 Jan; 76(1):179-183. PubMed ID: 33035321
[TBL] [Abstract][Full Text] [Related]
15. The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections.
Papp-Wallace KM
Expert Opin Pharmacother; 2019 Dec; 20(17):2169-2184. PubMed ID: 31500471
[No Abstract] [Full Text] [Related]
16. What the Clinical Microbiologist Should Know About Pharmacokinetics/Pharmacodynamics in the Era of Emerging Multidrug Resistance: Focusing on β-Lactam/β-Lactamase Inhibitor Combinations.
Abodakpi H; Wanger A; Tam VH
Clin Lab Med; 2019 Sep; 39(3):473-485. PubMed ID: 31383269
[TBL] [Abstract][Full Text] [Related]
17. Tackling the Antibiotic Resistance Caused by Class A
Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
[TBL] [Abstract][Full Text] [Related]
18. New β-lactam antibiotics and β-lactamase inhibitors.
Bush K; Macielag MJ
Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
[TBL] [Abstract][Full Text] [Related]
19. New promising β-lactamase inhibitors for clinical use.
Olsen I
Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1303-8. PubMed ID: 25864193
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
